News

The immunotherapeutic vaccine, AE37, is being developed by Generex' Antigen Express division in the US. The phase II study will enroll patients who have completed standard therapy for

AstraZeneca said that the deal was an important strategic step providing it with a technology platform in an area of research that complements its internal capabilities in antibacterials.

A federal court ruled that Synthon obtained, by inequitable conduct, two US patents alleged to cover a process and an intermediate compound used to make the active ingredient

The proposed transaction is expected to close within the next few days, subject to the satisfaction of the remaining closing conditions. Johnson & Johnson has bought Conor Medsystems

The decision comes after Pfizer recently reported plans to cut its workforce by 10%. The elimination of these jobs was implemented despite AstraZeneca reporting record fourth quarter profits

Neurochem said that it is on schedule to release the results of the clinical trial in spring this year. Alzhemed is the company's investigational product candidate aimed at

Included in the reduction are 40 home office employees and 23 field-based employees whose employment was terminated at the beginning of January 2007. Additionally, 62 Ligand employees will

Gliadel Wafer contains the cancer chemotherapeutic drug carmustine and is implanted directly into the tumor as an adjunct to surgery and radiation. The FDA said that the two-page

An independent data safety monitoring board advised the company to stop the trial based on an interim analysis of 351 events, indicating that the trial was highly unlikely